Top News
Latest News
INNOVATION
25 Feb 2026
Layered Nanoparticles Boost mRNA DeliveryPARTNERSHIPS
24 Feb 2026
Can Smarter Nanoparticles Unlock RNA’s Next Wave?INVESTMENT
23 Feb 2026
A £1B Shot in the Arm for UK Vaccine PowerMARKET TRENDS
19 Feb 2026
mRNA Groups Press Ahead in Cancer Push
How the Cloud Powers the Next mRNA Breakthrough
TECHNOLOGY
18 Feb 2026
Biotech firms are using cloud platforms to accelerate mRNA research while managing compliance, security, and rising costs
INNOVATION
25 Feb 2026
Layered Nanoparticles Boost mRNA Delivery
Core-shell lipid nanoparticles show early gains in mRNA release but raise new design and safety questions
PARTNERSHIPS
24 Feb 2026
Can Smarter Nanoparticles Unlock RNA’s Next Wave?
The partners aim to improve LNP stability and targeting as demand rises for scalable, next-generation RNA platforms
INVESTMENT
23 Feb 2026
A £1B Shot in the Arm for UK Vaccine Power
A £1B investment anchors UK mRNA production, with capacity for 100M doses and rapid emergency expansion
MARKET TRENDS
19 Feb 2026
mRNA Groups Press Ahead in Cancer Push
Personalised oncology programmes advance as regulators engage and payers scrutinise costs
TECHNOLOGY
18 Feb 2026
How the Cloud Powers the Next mRNA Breakthrough
Biotech firms are using cloud platforms to accelerate mRNA research while managing compliance, security, and rising costs
INSIGHTS
16 Feb 2026
Can Europe Win the mRNA Cancer Race?
A €6.9 million EU grant backs eTheRNA’s cancer vaccines and signals Europe’s long-term bet on mRNA oncology
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.